Transcriptional changes in bone marrow stromal cells of patients with heart failure

References

• Mirotsou M, Jayawardena TM, Schmeckpeper J, Gnecchi M, Dzau VJ. Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol 2011; 50:280 - 9; http://dx.doi.org/10.1016/j.yjmcc.2010.08.005; PMID: 20727900
   PubMed Web of Science ®Google Scholar
• Takashima S, Tempel D, Duckers HJ. Current outlook of cardiac stem cell therapy towards a clinical application. Heart 2013; 99:1772 - 84; http://dx.doi.org/10.1136/heartjnl-2012-303308; PMID: 23525708
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Leri A. Aging and disease as modifiers of efficacy of cell therapy. Circ Res 2008; 102:1319 - 30; http://dx.doi.org/10.1161/CIRCRESAHA.108.175943; PMID: 18535269
   PubMed Web of Science ®Google Scholar
• Wagner W, Bork S, Horn P, Krunic D, Walenda T, Diehlmann A, Benes V, Blake J, Huber FX, Eckstein V, et al. Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One 2009; 4:e5846; http://dx.doi.org/10.1371/journal.pone.0005846; PMID: 19513108
   PubMed Web of Science ®Google Scholar
• Hutchinson KR, Stewart JA Jr., Lucchesi PA. Extracellular matrix remodeling during the progression of volume overload-induced heart failure. J Mol Cell Cardiol 2010; 48:564 - 9; http://dx.doi.org/10.1016/j.yjmcc.2009.06.001; PMID: 19524591
   PubMed Web of Science ®Google Scholar
• Spinale FG, Janicki JS, Zile MR. Membrane-associated matrix proteolysis and heart failure. Circ Res 2013; 112:195 - 208; http://dx.doi.org/10.1161/CIRCRESAHA.112.266882; PMID: 23287455
   PubMed Web of Science ®Google Scholar
• Lijnen PJ, Maharani T, Finahari N, Prihadi JS. Serum collagen markers and heart failure. Cardiovasc Hematol Disord Drug Targets 2012; 12:51 - 5; http://dx.doi.org/10.2174/187152912801823147; PMID: 22524171
   PubMedGoogle Scholar
• Polyakova V, Loeffler I, Hein S, Miyagawa S, Piotrowska I, Dammer S, Risteli J, Schaper J, Kostin S. Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP/TIMP profiles. Int J Cardiol 2011; 151:18 - 33; http://dx.doi.org/10.1016/j.ijcard.2010.04.053; PMID: 20546954
   PubMed Web of Science ®Google Scholar
• Goldsmith EC, Bradshaw AD, Spinale FG. Cellular mechanisms of tissue fibrosis. 2. Contributory pathways leading to myocardial fibrosis: moving beyond collagen expression. Am J Physiol Cell Physiol 2013; 304:C393 - 402; http://dx.doi.org/10.1152/ajpcell.00347.2012; PMID: 23174564
   PubMedGoogle Scholar
• Heymans S, Lupu F, Terclavers S, Vanwetswinkel B, Herbert JM, Baker A, Collen D, Carmeliet P, Moons L. Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice. Am J Pathol 2005; 166:15 - 25; http://dx.doi.org/10.1016/S0002-9440(10)62228-6; PMID: 15631996
   PubMed Web of Science ®Google Scholar
• Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141:52 - 67; http://dx.doi.org/10.1016/j.cell.2010.03.015; PMID: 20371345
   PubMed Web of Science ®Google Scholar
• Spinale FG. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 2007; 87:1285 - 342; http://dx.doi.org/10.1152/physrev.00012.2007; PMID: 17928585
   PubMed Web of Science ®Google Scholar
• Moriwaki H, Stempien-Otero A, Kremen M, Cozen AE, Dichek DA. Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice. Circ Res 2004; 95:637 - 44; http://dx.doi.org/10.1161/01.RES.0000141427.61023.f4; PMID: 15297377
   PubMed Web of Science ®Google Scholar
• Meznarich J, Malchodi L, Helterline D, Ramsey SA, Bertko K, Plummer T, Plawman A, Gold E, Stempien-Otero A. Urokinase plasminogen activator induces pro-fibrotic/m2 phenotype in murine cardiac macrophages. PLoS One 2013; 8:e57837; http://dx.doi.org/10.1371/journal.pone.0057837; PMID: 23536772
   PubMedGoogle Scholar
• Margadant C, Sonnenberg A. Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep 2010; 11:97 - 105; http://dx.doi.org/10.1038/embor.2009.276; PMID: 20075988
   PubMed Web of Science ®Google Scholar
• Tatler AL, John AE, Jolly L, Habgood A, Porte J, Brightling C, Knox AJ, Pang L, Sheppard D, Huang X, et al. Integrin αvβ5-mediated TGF-β activation by airway smooth muscle cells in asthma. J Immunol 2011; 187:6094 - 107; http://dx.doi.org/10.4049/jimmunol.1003507; PMID: 22025551
   PubMed Web of Science ®Google Scholar
• Park SH. Fine tuning and cross-talking of TGF-beta signal by inhibitory Smads. J Biochem Mol Biol 2005; 38:9 - 16; http://dx.doi.org/10.5483/BMBRep.2005.38.1.009; PMID: 15715940
   PubMedGoogle Scholar
• Wang B, Omar A, Angelovska T, Drobic V, Rattan SG, Jones SC, Dixon IM. Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblasts. Am J Physiol Heart Circ Physiol 2007; 293:H1282 - 90; http://dx.doi.org/10.1152/ajpheart.00910.2006; PMID: 17513491
   PubMedGoogle Scholar
• He X, Gao X, Peng L, Wang S, Zhu Y, Ma H, Lin J, Duan DD. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7. Circ Res 2011; 108:164 - 75; http://dx.doi.org/10.1161/CIRCRESAHA.110.234369; PMID: 21127293
   PubMed Web of Science ®Google Scholar
• Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K. Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts. Arthritis Rheum 2005; 52:2897 - 905; http://dx.doi.org/10.1002/art.21246; PMID: 16142753
   PubMed Web of Science ®Google Scholar
• Asano Y, Ihn H, Yamane K, Jinnin M, Tamaki K. Increased expression of integrin alphavbeta5 induces the myofibroblastic differentiation of dermal fibroblasts. Am J Pathol 2006; 168:499 - 510; http://dx.doi.org/10.2353/ajpath.2006.041306; PMID: 16436664
   PubMed Web of Science ®Google Scholar
• Dendooven A, Gerritsen KG, Nguyen TQ, Kok RJ, Goldschmeding R. Connective tissue growth factor (CTGF/CCN2) ELISA: a novel tool for monitoring fibrosis. Biomarkers 2011; 16:289 - 301; http://dx.doi.org/10.3109/1354750X.2011.561366; PMID: 21595567
   PubMed Web of Science ®Google Scholar
• Lipson KE, Wong C, Teng Y, Spong S. CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. Fibrogenesis Tissue Repair 2012; 5:Suppl 1 S24; http://dx.doi.org/10.1186/1755-1536-5-S1-S24; PMID: 23259531
   PubMedGoogle Scholar
• Koitabashi N, Arai M, Kogure S, Niwano K, Watanabe A, Aoki Y, Maeno T, Nishida T, Kubota S, Takigawa M, et al. Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension 2007; 49:1120 - 7; http://dx.doi.org/10.1161/HYPERTENSIONAHA.106.077537; PMID: 17372041
   PubMed Web of Science ®Google Scholar
• Koitabashi N, Arai M, Niwano K, Watanabe A, Endoh M, Suguta M, Yokoyama T, Tada H, Toyama T, Adachi H, et al. Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure. Eur J Heart Fail 2008; 10:373 - 9; http://dx.doi.org/10.1016/j.ejheart.2008.02.011; PMID: 18337169
   PubMed Web of Science ®Google Scholar
• Alfaro MP, Deskins DL, Wallus M, DasGupta J, Davidson JM, Nanney LB, A Guney M, Gannon M, Young PP. A physiological role for connective tissue growth factor in early wound healing. Lab Invest 2013; 93:81 - 95; http://dx.doi.org/10.1038/labinvest.2012.162; PMID: 23212098
   PubMed Web of Science ®Google Scholar
• Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 2009; 19:156 - 72; http://dx.doi.org/10.1038/cr.2009.5; PMID: 19153598
   PubMed Web of Science ®Google Scholar
• Batlle R, Alba-Castellón L, Loubat-Casanovas J, Armenteros E, Francí C, Stanisavljevic J, Banderas R, Martin-Caballero J, Bonilla F, Baulida J, et al. Snail1 controls TGF-β responsiveness and differentiation of mesenchymal stem cells. Oncogene 2013; 32:3381 - 9; http://dx.doi.org/10.1038/onc.2012.342; PMID: 22869142
   PubMed Web of Science ®Google Scholar
• Yokoyama K, Kamata N, Fujimoto R, Tsutsumi S, Tomonari M, Taki M, Hosokawa H, Nagayama M. Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas. Int J Oncol 2003; 22:891 - 8; PMID: 12632084
   PubMed Web of Science ®Google Scholar
• Rowe RG, Li XY, Hu Y, Saunders TL, Virtanen I, Garcia de Herreros A, Becker KF, Ingvarsen S, Engelholm LH, Bommer GT, et al. Mesenchymal cells reactivate Snail1 expression to drive three-dimensional invasion programs. J Cell Biol 2009; 184:399 - 408; http://dx.doi.org/10.1083/jcb.200810113; PMID: 19188491
   PubMed Web of Science ®Google Scholar
• Freedman JE, Larson MG, Tanriverdi K, O’Donnell CJ, Morin K, Hakanson AS, Vasan RS, Johnson AD, Iafrati MD, Benjamin EJ. Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart study. Circulation 2010; 122:119 - 29; http://dx.doi.org/10.1161/CIRCULATIONAHA.109.928192; PMID: 20606121
   PubMed Web of Science ®Google Scholar
• Pemu PE, Anderson L, Gee BE, Ofili EO, Ghosh S. Early alterations of the immune transcriptome in cultured progenitor cells from obese African-American women. Obesity (Silver Spring) 2012; 20:1481 - 90; http://dx.doi.org/10.1038/oby.2011.370; PMID: 22262158
   PubMed Web of Science ®Google Scholar
• Philip-Couderc P, Pathak A, Smih F, Dambrin C, Harmancey R, Buys S, Galinier M, Massabuau P, Roncalli J, Senard JM, et al. Uncomplicated human obesity is associated with a specific cardiac transcriptome: involvement of the Wnt pathway. FASEB J 2004; 18:1539 - 40; PMID: 15289443
   PubMed Web of Science ®Google Scholar
• von Haehling S, Lainscak M, Doehner W, Ponikowski P, Rosano G, Jordan J, Rozentryt P, Rauchhaus M, Karpov R, Tkachuk V, et al. Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). J Cachexia Sarcopenia Muscle 2010; 1:187 - 94; http://dx.doi.org/10.1007/s13539-010-0013-3; PMID: 21475696
   PubMed Web of Science ®Google Scholar
• Dmitrieva RI, Minullina IR, Bilibina AA, Tarasova OV, Anisimov SV, Zaritskey AY. Bone marrow- and subcutaneous adipose tissue-derived mesenchymal stem cells: differences and similarities. Cell Cycle 2012; 11:377 - 83; http://dx.doi.org/10.4161/cc.11.2.18858; PMID: 22189711
   PubMed Web of Science ®Google Scholar